Skip to main content
Clinical Trials/NCT02037711
NCT02037711
Completed
Phase 4

Intraperitoneal Instillation of Levobupivacaine in Laparoscopic Pediatric Procedures

Cairo University1 site in 1 country40 target enrollmentMay 2013

Overview

Phase
Phase 4
Intervention
Levobupivacaine 0.5%
Conditions
Pain
Sponsor
Cairo University
Enrollment
40
Locations
1
Primary Endpoint
Postoperative Pain scoring (CHEOPS)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Pain after laparoscopic surgery has been associated with surgical manipulations, including intraperitoneal insufflation of carbon dioxide (CO2), resulting in peritoneal stretching, diaphragmatic irritation, changes in intra-abdominal pH, and retention of the insufflated gas in the abdominal cavity after surgery. These effects may result in the irritation of peritoneal nerves causing visceral pain, as commonly reported after laparoscopic procedures in pediatrics.

The study hypothesis is that Intraperitoneal local anesthetic (levobupivacaine) instillation can provide pain relief after laparoscopic surgery, but local anesthetic distribution may not always be uniform throughout the peritoneal surface. Many methods were tried for intraperitoneal application of local anesthetics in laparoscopic surgery such as local anesthetic (LA) instillation and LA nebulization.

-But these methods are not widely used in pediatrics upon our knowledge

Registry
clinicaltrials.gov
Start Date
May 2013
End Date
November 2013
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sherif Mohamed Abd el moneim Soaida, MD

Lecturer

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Patient undergoing laparoscopic surgeries
  • Pediatric weighing 4 kg or more
  • Patients with free medical history

Exclusion Criteria

  • Parents refusal
  • Known allergy to levobupivacaine
  • Acute preoperative pain other than biliary colic
  • chronic pain treatment or antiepileptic therapy
  • Severe hepatic or renal impairment
  • Cognitive impairment or communication problems.

Arms & Interventions

Chirocaine group (levobupivacaine )

Intervention: Levobupivacaine 0.5%

Control group

Intervention: Normal saline

Outcomes

Primary Outcomes

Postoperative Pain scoring (CHEOPS)

Time Frame: up to six hours

pain score will be assessed immediately postoperative, then after 1 hour, 2 hours, and 6 hours.

Secondary Outcomes

  • changes in Haemodynamics including ( Non Invasive Blood Pressure)(during the period of the operation (Preoperative, post-induction, after instillation of levobupivacaine or saline, postoperative for 6 hours at 0-1-2- 6)
  • changes in Haemodynamics including ( Heart Rate)(during the period of the operation (Preoperative, post-induction, after instillation of levobupivacaine or saline, postoperative for 6 hours at 0-1-2-6)

Study Sites (1)

Loading locations...

Similar Trials